Chemed Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
Chemed Corp Stock Forecast and Price Target
The average price target for Chemed Corp's stock lately set by several renowned analysts is $696.50, which would result in a potential upside of approximately 16% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $712.00 and a low estimate of $650.00. Although you may not be interested in CHE stock, you should still be aware of its competitors.
16.00% Upside
Chemed Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Chemed Corp's Price has fallen from $491.60 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $625.64 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LHCG Stock Forecast | LHC Group | - |
14
|
$169.81 | Buy/Sell | $170.00 | -100.00% |
| AMED Stock Forecast | Amedisys | Hold |
16
|
$90.40 | Buy/Sell | $97.00 | 11.73% |
| SGFY Stock Forecast | Signify Health | - |
2
|
$30.49 | Buy/Sell | $0.00 | -100.00% |
| ADUS Stock Forecast | Addus HomeCare | Buy |
16
|
$97.19 | Buy/Sell | $111.14 | 8.04% |
| APR Stock Forecast | Apria | - |
16
|
$37.50 | Buy/Sell | $37.50 | -100.00% |
Chemed Corp Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Chemed Corp's Revenue has grown, rising from $2.08B to $2.26B – a growth of 8.89%. In the next year, analysts believe that Revenue will reach $2.40B – an increase of 5.81%. For the next eight years, the forecast is for Revenue to grow by 9.33%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVAH Stock Forecast | Aveanna Healthcare Holdings | Hold |
8
|
$2.29 | Buy/Sell | $2.35 | 20.09% |
| OCLG Stock Forecast | Oncologix Tech | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| BBAL Stock Forecast | New York Health Care | - |
0
|
$0.00 | Buy/Sell | $8.00 | 0.00% |
.jpg)
Chemed Corp Dividend per Share Forecast for 2023 - 2025 - 2030
Chemed Corp's Dividend per Share has grown In the last two years, rising from $1.32 to $1.48 – a growth of 12.12%. In the next year, analysts believe that Dividend per Share will reach $1.60 – an increase of 8.11%. For the next seven years, experts predict that Chemed Corp's Dividend per Share will grow at a rate of 4.88%.
Chemed Corp EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Chemed Corp's EBITDA has grown by 9.78%, rising from $365.67M to $401.43M. For the next year, analysts predict that EBITDA will reach $505.65M – an increase of 25.96%. Over the next seven years, experts believe that Chemed Corp's EBITDA will grow at a rate of 35.45%.
Chemed Corp EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Chemed Corp's EBIT has grown, moving from $314.59M to $340.57M – an increase of 8.26%. In the next year, analysts predict that EBIT will jump to $428.58M – up 25.84% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 44.70%.
Chemed Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Chemed Corp's EPS has fallen from $18.08 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $23.01 – an increase of 100.00%. For the next eight years, the forecast is for EPS to grow by 100.00%.
.jpg)